TP53 and cancer: Remarkably, the conventional driver mutations (TP53, RAS, and SMAD4) consistently emerged simultaneously rather than being acquired sequentially after the initiation of cancer growth, as exemplified in FAP.02, FAP.04, and FAP.09 (Figure 5).